Comparison of Apoptotic Inducing Effect of Zerumbone and Zerumbone-Loaded Nanostructured Lipid Carrier on Human Mammary Adenocarcinoma MDA-MB-231 Cell Line

Figure 5

MDA-MB-231 cell treated with ZER and ZER-NLC and labeled with FITC-conjugated Annexin V and propidium iodide. ((a), (b), (c)) untreated cells, ((d), (e), (f)) cells treated with ZER, and ((g), (h), (i)) cells treated with ZER-NLC. Cells were treated for 12, 24, and 48 hours.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)